13
Views
6
CrossRef citations to date
0
Altmetric
Original Article

Toxicity Profile of the Investigational New Biotherapeutic Agent, B43 (Anti-CD 19)-Pokeweed Antiviral Protein Immunotoxin

, , , , , , , , & show all
Pages 61-70 | Received 10 Aug 1995, Published online: 01 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Onur Ek, Yuri Yanishevskic, Tamer Zeren, Barbara Waurzyniak, Roland Gunther, Lisa Chelstrom, Mridula Chandan-Langlie, Elizabeth Schneider, Dorothea E. Myers, William Evans & Fatih M. Uckun. (1998) In Vivo., Toxicity and Pharmacokinetic Features of B43(Anti-CD19)-Genistein Immunoconjugate. Leukemia & Lymphoma 30:3-4, pages 389-394.
Read now

Articles from other publishers (4)

Marta Kijanka, Bram Dorresteijn, Sabrina Oliveira & Paul MP van Bergen en Henegouwen. (2015) Nanobody-based cancer therapy of solid tumors. Nanomedicine 10:1, pages 161-174.
Crossref
Wendy Halpern & David Hutto. 2013. Haschek and Rousseaux's Handbook of Toxicologic Pathology. Haschek and Rousseaux's Handbook of Toxicologic Pathology 751 782 .
Fatih M Uckun, Larisa Rustamova, Alexei O Vassilev, Heather E Tibbles & Alexander S Petkevich. (2005) CNS activity of Pokeweed Anti-viral Protein (PAP) in mice infected with Lymphocytic Choriomeningitis Virus (LCMV). BMC Infectious Diseases 5:1.
Crossref
DOROTHEA E. MYERS & FATIH M. UCKUN. (1999) In Vivo Toxicity, Pharmacokinetic Features, and Immunogenicity of B43(Anti-CD19)-Genistein Immunoconjugate in Mice and Non-human Primates. Journal of Medicinal Food 2:3-4, pages 173-175.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.